Pepmic Co., Ltd

Pepmic Co., Ltd is a leading player in the biotechnology and life sciences industries, offering a range of services in molecular biology and immunology, particularly focused on peptides, antibodies, proteins, and genes. Since 2010, Pepmic has built a strong reputation for providing high-quality solutions, including peptide synthesis, monoclonal antibody development, protein expression, and gene synthesis. The company's commitment to comprehensive and integrated services aims to empower clients in efficiently conducting their research projects. Pepmic's expertise, scientific knowledge, and experience position it as a reliable partner for gene and peptide synthesis, antibody development, and protein production. The company's customizable services revolve around four areas: peptide synthesis, purification, and conjugation; protein expression and purification in various cell types; as well as monoclonal and polyclonal antibody production alongside gene synthesis. While specific details regarding headquarter location, last investment, and investors are not available, Pepmic’s dedication to advancing solutions in life sciences reflects an attractive opportunity for venture capital investment.